Simultaneous derivation, validation, and comparison of predictor hazard ratios for cardiovascular risk prediction equations in patients with diabetes from high versus non-high income countries: cohort study

The BMJ Pub Date : 2026-09-11 DOI:10.1136/bmj-2026-100535
Jingyuan Liang,Yeunhyang Choi,Peng Shen,Susan Wells,Katrina Poppe,Zhangping Fu,Matire Harwood,Xiaofei Liu,Sue Crengle,Ting Wang,Corina Grey,Hongbo Lin,Suneela Mehta,Xun Tang,Rod Jackson,Pei Gao
{"title":"Simultaneous derivation, validation, and comparison of predictor hazard ratios for cardiovascular risk prediction equations in patients with diabetes from high versus non-high income countries: cohort study","authors":"Jingyuan Liang,Yeunhyang Choi,Peng Shen,Susan Wells,Katrina Poppe,Zhangping Fu,Matire Harwood,Xiaofei Liu,Sue Crengle,Ting Wang,Corina Grey,Hongbo Lin,Suneela Mehta,Xun Tang,Rod Jackson,Pei Gao","doi":"10.1136/bmj-2026-100535","DOIUrl":null,"url":null,"abstract":"Abstract Objective To directly test the generalisability of cardiovascular disease (CVD) risk predictor effects across populations in a high income versus non-high income country, derive comparable risk equations, and identify more effective strategies for prediction across populations. Design Population based cohort study. Setting Primary prevention cohorts in New Zealand and China. Participants Equivalent New Zealand and Chinese cohorts of people aged 30-74 years with diabetes and no CVD based on electronic health records. Main outcome measures Country specific five year equations were derived using standardised methods to predict first cardiovascular events; predictor hazard ratios were compared. New Zealand equations were applied to the Chinese cohort, with performance assessed before and after standard recalibration, followed by the updating of predictor hazard ratios that differed statistically significantly. Results Between 2004 and 2018, 47 958 New Zealand participants had 5622 (11.7%) first CVD events. Between 2010 and 2018, 46 558 Chinese participants had 3650 (7.8%) first CVD events. Sex specific equations included 16 predictors. Hazard ratios for most predictors were similar between New Zealand and Chinese equations but differed markedly for age (eg, women: 1.61, 95% confidence interval 1.51 to 1.71 per 10 years in New Zealand, 2.51 (2.32 to 2.72) per 10 years in China). Standard recalibration of New Zealand equations did not improve calibration in the Chinese cohort (expected to observed ratio: 0.938 in men, 0.809 in women). Replacing New Zealand age coefficients with Chinese coefficients noticeably improved calibration (expected to observed ratio 1.027 in men, 1.025 in women). Conclusions Applying a high income country derived CVD risk prediction equation to a population from a non-high income country with diabetes may introduce systematic errors, primarily driven by differences in the effect of age. Moving beyond simple recalibration to updating key predictor coefficients, particularly age, should be considered for more accurate risk stratification. This study highlights potential limitations of high income country equation updating practices and proposes a feasible approach to improve their accuracy when used in populations from non-high income countries.","PeriodicalId":22388,"journal":{"name":"The BMJ","volume":"76 1","pages":"e100535"},"PeriodicalIF":0.0000,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The BMJ","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmj-2026-100535","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract Objective To directly test the generalisability of cardiovascular disease (CVD) risk predictor effects across populations in a high income versus non-high income country, derive comparable risk equations, and identify more effective strategies for prediction across populations. Design Population based cohort study. Setting Primary prevention cohorts in New Zealand and China. Participants Equivalent New Zealand and Chinese cohorts of people aged 30-74 years with diabetes and no CVD based on electronic health records. Main outcome measures Country specific five year equations were derived using standardised methods to predict first cardiovascular events; predictor hazard ratios were compared. New Zealand equations were applied to the Chinese cohort, with performance assessed before and after standard recalibration, followed by the updating of predictor hazard ratios that differed statistically significantly. Results Between 2004 and 2018, 47 958 New Zealand participants had 5622 (11.7%) first CVD events. Between 2010 and 2018, 46 558 Chinese participants had 3650 (7.8%) first CVD events. Sex specific equations included 16 predictors. Hazard ratios for most predictors were similar between New Zealand and Chinese equations but differed markedly for age (eg, women: 1.61, 95% confidence interval 1.51 to 1.71 per 10 years in New Zealand, 2.51 (2.32 to 2.72) per 10 years in China). Standard recalibration of New Zealand equations did not improve calibration in the Chinese cohort (expected to observed ratio: 0.938 in men, 0.809 in women). Replacing New Zealand age coefficients with Chinese coefficients noticeably improved calibration (expected to observed ratio 1.027 in men, 1.025 in women). Conclusions Applying a high income country derived CVD risk prediction equation to a population from a non-high income country with diabetes may introduce systematic errors, primarily driven by differences in the effect of age. Moving beyond simple recalibration to updating key predictor coefficients, particularly age, should be considered for more accurate risk stratification. This study highlights potential limitations of high income country equation updating practices and proposes a feasible approach to improve their accuracy when used in populations from non-high income countries.
高收入国家与非高收入国家糖尿病患者心血管风险预测方程预测因子风险比的同时推导、验证和比较:队列研究
目的直接检验高收入国家与非高收入国家人群中心血管疾病(CVD)风险预测因子效应的普遍性,推导可比较的风险方程,并确定更有效的人群预测策略。设计基于人群的队列研究。在新西兰和中国设置一级预防队列。参与者:基于电子健康记录的新西兰和中国同等年龄的30-74岁糖尿病患者,无心血管疾病。主要结局指标:采用标准化方法推导国家特定五年方程,预测首次心血管事件;比较预测因子风险比。将新西兰方程应用于中国队列,在标准重新校准前后评估其表现,随后更新具有统计学显著差异的预测因子风险比。2004年至2018年期间,47958名新西兰参与者发生了5622例(11.7%)首次心血管疾病事件。2010年至2018年期间,46558名中国参与者有3650例(7.8%)首次心血管疾病。性别特定方程包括16个预测因子。大多数预测因子的风险比在新西兰和中国方程之间相似,但在年龄方面存在显著差异(例如,女性:1.61,新西兰的95%置信区间为1.51至1.71 / 10年,中国为2.51(2.32至2.72)/ 10年)。新西兰方程的标准重新校准并没有改善中国队列的校准(预计观察到的比率:男性0.938,女性0.809)。用中国系数代替新西兰年龄系数显著改善了校准(预计观察到男性的比值为1.027,女性为1.025)。结论:将高收入国家导出的心血管疾病风险预测方程应用于非高收入国家的糖尿病患者可能会引入系统误差,主要是由年龄影响的差异造成的。从简单的重新校准到更新关键的预测系数,特别是年龄,应该考虑更准确的风险分层。本研究强调了高收入国家方程更新实践的潜在局限性,并提出了一种可行的方法,以提高其在非高收入国家人口中使用时的准确性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书